▶ 調査レポート

アルファサラセミア治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
• 英文タイトル：Global Alpha Thalassemia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。アルファサラセミア治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） / Global Alpha Thalassemia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR08C0199資料のイメージです。• レポートコード：B-GIR08C0199
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール
• 産業分類：Medical Care
• 販売価格（消費税別）
  Single User￥522,000 (USD3,480)▷ お問い合わせ
  Corporate User￥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートは、アルファサラセミア治療の世界市場について調べ、まとめました。種類別セグメントは、葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素等、用途別セグメントは、等に区分しました。アルファサラセミア治療の世界市場概観、企業動向、企業別アルファサラセミア治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・アルファサラセミア治療の市場概観
・アルファサラセミア治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・アルファサラセミア治療の企業別販売動向、市場シェア、市場集中度、競争動向
・アルファサラセミア治療の世界市場規模
・アルファサラセミア治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・アルファサラセミア治療のアメリカ市場規模推移
・アルファサラセミア治療のカナダ市場規模推移
・アルファサラセミア治療のメキシコ市場規模推移
・アルファサラセミア治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・アルファサラセミア治療のドイツ市場規模推移
・アルファサラセミア治療のイギリス市場規模推移
・アルファサラセミア治療のロシア市場規模推移
・アルファサラセミア治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・アルファサラセミア治療の日本市場規模推移
・アルファサラセミア治療の中国市場規模推移
・アルファサラセミア治療の韓国市場規模推移
・アルファサラセミア治療のインド市場規模推移
・アルファサラセミア治療の東南アジア市場規模推移
・アルファサラセミア治療の南米市場分析（ブラジル、アルゼンチン等）
・アルファサラセミア治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・アルファサラセミア治療の種類別分析/販売量、売上、市場シェア（葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素）
・アルファサラセミア治療の用途別分析/市場規模（）
・アルファサラセミア治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・アルファサラセミア治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Alpha Thalassemia Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Alpha Thalassemia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Alpha Thalassemia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Alpha Thalassemia Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Gilead Sciences, Inc.
Acceleron Pharma
Novartis AG
GlaxoSmithKline
Bellicum Pharmaceuticals
Merck & Co.
Johnson & Johnson

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Folic Acid
Deferasirox
Deferiprone
Hydroxyurea

Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others

レポート目次

Table of Contents

1 Alpha Thalassemia Treatment Market Overview
1.1 Product Overview and Scope of Alpha Thalassemia Treatment
1.2 Classification of Alpha Thalassemia Treatment by Types
1.2.1 Global Alpha Thalassemia Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Alpha Thalassemia Treatment Revenue Market Share by Types in 2018
1.2.3 Folic Acid
1.2.4 Deferasirox
1.2.5 Deferiprone
1.2.6 Hydroxyurea
1.3 Global Alpha Thalassemia Treatment Market by Application
1.3.1 Global Alpha Thalassemia Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Alpha Thalassemia Treatment Market by Regions
1.4.1 Global Alpha Thalassemia Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Alpha Thalassemia Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Alpha Thalassemia Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alpha Thalassemia Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Alpha Thalassemia Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alpha Thalassemia Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Alpha Thalassemia Treatment (2014-2024)
2 Company Profiles
2.1 Gilead Sciences, Inc.
2.1.1 Business Overview
2.1.2 Alpha Thalassemia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Acceleron Pharma
2.2.1 Business Overview
2.2.2 Alpha Thalassemia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Acceleron Pharma Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Alpha Thalassemia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Alpha Thalassemia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bellicum Pharmaceuticals
2.5.1 Business Overview
2.5.2 Alpha Thalassemia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck & Co.
2.6.1 Business Overview
2.6.2 Alpha Thalassemia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck & Co. Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Alpha Thalassemia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alpha Thalassemia Treatment Market Competition, by Players
3.1 Global Alpha Thalassemia Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Alpha Thalassemia Treatment Players Market Share
3.2.2 Top 10 Alpha Thalassemia Treatment Players Market Share
3.3 Market Competition Trend
4 Global Alpha Thalassemia Treatment Market Size by Regions
4.1 Global Alpha Thalassemia Treatment Revenue and Market Share by Regions
4.2 North America Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
5 North America Alpha Thalassemia Treatment Revenue by Countries
5.1 North America Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
5.2 USA Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
6 Europe Alpha Thalassemia Treatment Revenue by Countries
6.1 Europe Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
6.2 Germany Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
6.4 France Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Alpha Thalassemia Treatment Revenue by Countries
7.1 Asia-Pacific Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
7.2 China Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
7.5 India Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
8 South America Alpha Thalassemia Treatment Revenue by Countries
8.1 South America Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
8.2 Brazil Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Alpha Thalassemia Treatment by Countries
9.1 Middle East and Africa Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
10 Global Alpha Thalassemia Treatment Market Segment by Type
10.1 Global Alpha Thalassemia Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Alpha Thalassemia Treatment Market Forecast by Type (2019-2024)
10.3 Folic Acid Revenue Growth Rate (2014-2024)
10.4 Deferasirox Revenue Growth Rate (2014-2024)
10.5 Deferiprone Revenue Growth Rate (2014-2024)
10.6 Hydroxyurea Revenue Growth Rate (2014-2024)
11 Global Alpha Thalassemia Treatment Market Segment by Application
11.1 Global Alpha Thalassemia Treatment Revenue Market Share by Application (2014-2019)
11.2 Alpha Thalassemia Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Alpha Thalassemia Treatment Market Size Forecast (2019-2024)
12.1 Global Alpha Thalassemia Treatment Market Size Forecast (2019-2024)
12.2 Global Alpha Thalassemia Treatment Market Forecast by Regions (2019-2024)
12.3 North America Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
12.6 South America Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Alpha Thalassemia Treatment Picture
Table Product Specifications of Alpha Thalassemia Treatment
Table Global Alpha Thalassemia Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Alpha Thalassemia Treatment Revenue Market Share by Types in 2018
Figure Folic Acid Picture
Figure Deferasirox Picture
Figure Deferiprone Picture
Figure Hydroxyurea Picture
Table Global Alpha Thalassemia Treatment Revenue (Million USD) by Application (2014-2024)
Figure Alpha Thalassemia Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market Alpha Thalassemia Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences, Inc. Alpha Thalassemia Treatment Type and Applications
Table Gilead Sciences, Inc. Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Acceleron Pharma Basic Information, Manufacturing Base and Competitors
Table Acceleron Pharma Alpha Thalassemia Treatment Type and Applications
Table Acceleron Pharma Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Alpha Thalassemia Treatment Type and Applications
Table Novartis AG Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Alpha Thalassemia Treatment Type and Applications
Table GlaxoSmithKline Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Alpha Thalassemia Treatment Type and Applications
Table Bellicum Pharmaceuticals Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Alpha Thalassemia Treatment Type and Applications
Table Merck & Co. Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Alpha Thalassemia Treatment Type and Applications
Table Johnson & Johnson Alpha Thalassemia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Alpha Thalassemia Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue Share by Players (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Share by Players in 2017
Figure Global Alpha Thalassemia Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Alpha Thalassemia Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Alpha Thalassemia Treatment Revenue Market Share in 2018
Figure Global Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Market Share by Regions in 2018
Figure North America Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure South America Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table North America Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
Table North America Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Alpha Thalassemia Treatment Revenue Market Share by Countries in 2018
Figure USA Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table Europe Alpha Thalassemia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Alpha Thalassemia Treatment Revenue Market Share by Countries in 2018
Figure Germany Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure UK Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure France Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Alpha Thalassemia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Alpha Thalassemia Treatment Revenue Market Share by Countries in 2018
Figure China Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure India Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table South America Alpha Thalassemia Treatment Revenue by Countries (2014-2019)
Table South America Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Alpha Thalassemia Treatment Revenue Market Share by Countries in 2018
Figure Brazil Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Alpha Thalassemia Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alpha Thalassemia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alpha Thalassemia Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Alpha Thalassemia Treatment Revenue and Growth Rate (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue Share by Type (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Share by Type (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Share by Type in 2018
Table Global Alpha Thalassemia Treatment Revenue Forecast by Type (2019-2024)
Figure Global Alpha Thalassemia Treatment Market Share Forecast by Type (2019-2024)
Figure Global Folic Acid Revenue Growth Rate (2014-2019)
Figure Global Deferasirox Revenue Growth Rate (2014-2019)
Figure Global Deferiprone Revenue Growth Rate (2014-2019)
Figure Global Hydroxyurea Revenue Growth Rate (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue by Application (2014-2019)
Table Global Alpha Thalassemia Treatment Revenue Share by Application (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Share by Application (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Share by Application in 2018
Table Global Alpha Thalassemia Treatment Revenue Forecast by Application (2019-2024)
Figure Global Alpha Thalassemia Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Alpha Thalassemia Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Alpha Thalassemia Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
Figure Europe Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
Figure South America Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Alpha Thalassemia Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 世界のサラセミア市場：市場規模・現状・予測
    Global Thalassemia Market Size, Status and Forecast 2019-2025
    QYR9N8115 2019年6月14日 92Pages
    当資料は、サラセミアのグローバル市場について調査・分析したレポートで、種類別（病院、診療所、研究所、実験室）、用途別（ブルーバードバイオ株式会社、株式会社アクセロンファーマ、セルジーン株式会社、グラクソスミスクライン社、インサイト社（株）、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南...
  • ブチル化α-シクロデキストリンの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）
    Global Butylated Alpha-Cyclodextrin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    B-GIR08C0969 2019年8月 107Pages
    本調査レポートは、ブチル化α-シクロデキストリンの世界市場について調べ、まとめました。種類別セグメントは、タイプⅠ、タイプⅡ等、用途別セグメントは、アプリケーションI、アプリケーションII等に区分しました。ブチル化α-シクロデキストリンの世界市場概観、企業動向、企業別ブチル化α-シクロデキストリンシ...
  • すくみ足治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Freezing of Gait Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C2406 2019年7月 102Pages
    本調査レポートは、すくみ足治療の世界市場について調べ、まとめました。種類別セグメントは、経口ドーパミン作動薬、ウェアラブルおよび歩行補助器具、深部脳刺激、その他等、用途別セグメントは、等に区分しました。すくみ足治療の世界市場概観、企業動向、企業別すくみ足治療シェア、市場規模推移、市場規模予測（201...
  • 幹細胞脱毛症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Stem Cell Alopecia Treatment  Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C5523 2019年7月 105Pages
    本調査レポートは、幹細胞脱毛症治療の世界市場について調べ、まとめました。種類別セグメントは、円形脱毛症、全頭脱毛症、全身性脱毛症等、用途別セグメントは、等に区分しました。幹細胞脱毛症治療の世界市場概観、企業動向、企業別幹細胞脱毛症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要...
  • くる病治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Rickets Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C4958 2019年7月 115Pages
    本調査レポートは、くる病治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンDサプリメント、カルシウムサプリメント等、用途別セグメントは、等に区分しました。くる病治療の世界市場概観、企業動向、企業別くる病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析...
  • ビタミンD欠乏症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Vitamin D Deficiency Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C6250 2019年7月 123Pages
    本調査レポートは、ビタミンD欠乏症治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンD2、ビタミンD3等、用途別セグメントは、等に区分しました。ビタミンD欠乏症治療の世界市場概観、企業動向、企業別ビタミンD欠乏症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主...
  • 骨格異形成症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Skeletal Dysplasia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C5224 2019年7月 124Pages
    本調査レポートは、骨格異形成症治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンDサプリメント、カルシウムサプリメント、その他等、用途別セグメントは、等に区分しました。骨格異形成症治療の世界市場概観、企業動向、企業別骨格異形成症治療シェア、市場規模推移、市場規模予測（2019年-...
  • 小児期欠神癲癇治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Childhood Absence Epilepsy Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C1205 2019年7月 121Pages
    本調査レポートは、小児期欠神癲癇治療の世界市場について調べ、まとめました。種類別セグメントは、エトサクシミド、バルプロエート、ラモトリジン、CX-8998、カンナビジオール経口液剤等、用途別セグメントは、等に区分しました。小児期欠神癲癇治療の世界市場概観、企業動向、企業別小児期欠神癲癇治療シェア、市...
  • 学習障害治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Learning Disability Treatment  Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C3309 2019年7月 101Pages
    本調査レポートは、学習障害治療の世界市場について調べ、まとめました。種類別セグメントは、興奮剤、非興奮剤、その他の薬等、用途別セグメントは、等に区分しました。学習障害治療の世界市場概観、企業動向、企業別学習障害治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨー...
  • レア血液学的治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Rare Hematology Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C4856 2019年7月 121Pages
    本調査レポートは、レア血液学的治療の世界市場について調べ、まとめました。種類別セグメントは、血漿由来因子、組換え因子等、用途別セグメントは、等に区分しました。レア血液学的治療の世界市場概観、企業動向、企業別レア血液学的治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北...